Background and Aims: Occult hepatitis B virus infection (OBI) is known as an important source of hepatitis B virus (HBV) infection. It is categorized as Hepatitis B surface antigen (HBsAg) not being present and low DNA viral load in serum. In this study, an attempt was made to investigate the outbreak of anti-HBc and OBI among the HBsAg-negative donors in Golestan province.
Introduction

Hepatitis B virus (HBV) infection as a main
health-threatening factor can result in hepatic cirrhosis, primary liver cancer, and chronic hepatitis [1, 2] . The estimations presented by World Health Organization (WHO) indicate that HBV has affected 450 million individuals around the world [3] . Generally, HBsAg is a sign of HBV infection and the removal of this antigen simply demonstrates HBV disappearance [4] .
Almost 35% of people in the world are infected with HBV and 75% of the chronic people are in Asia [5] . Southeast Asia is one of the high endemicity areas in which more than 8% of the people are chronic HBV carriers. The Middle East is a region with a moderate endemicity to HBV out of which 2% to 7% of the populations are carriers of chronic HBV [6] . The introduction of HBsAg in the early 1970s was the first successful attempt to promote transfusion safety [7] .
Nevertheless, as reported in the early 1978 [8] , HBV infection is likely to be transferred through HBsAg-negative blood products in the critical stage of the infection throughout either the seronegative window period or chronic phases with unnoticeable HBsAg called occult Hepatitis B infection (OBI) [4] .
The presence of HBV-DNA (less than 200 IU/mL) in the liver or serum of HBsAg negative patients with or without anti-HBc positivity is the most important characteristic of the OBI. Furthermore, 20% of the subjects show no symptom of HBV serological marker [9] . In these individuals, this antigen fails to be identified through conventional serological techniques even if there is a virus in peripheral blood and liver [10] . Therefore, HBV-DNA in either liver tissue or serum of the blood donors with OBI is the main cause of HBV infection even if there is no noticeable HBsAg with/without anti-HBc or anti-HBs antibodies [11] ; therefore, anti-HBc and HBV-DNA are highly significant measures to decrease post transfusion hepatitis [12] .
Recently, the frequency of HBsAg in Iran has been estimated to be in a range of 1.7% to 5% and the HBV infection epidemiology has shifted from vertical to horizontal transmission. Approximately, 72% of the subjects with hepatocellular carcinoma (HCC) are infected with HBV in Iran, and more to the point, 46% of them are carriers of hepatitis B (HBcAb positive). These findings suggest that hepatitis B is the most prevalent source of liver cancer and cirrhosis in Iran [13] . The outbreak of anti-HBc in Iranian blood donors has been reported to range between 2.1-11.5% [14] [15] [16] [17] [18] [19] [20] .
The Golestan province in the north of Iran has a high outbreak of HBV [21] . The spread of anti-HBc and HBsAg in the general population of this province was reported to be 36.9% and 5.1%, respectively [22] . Therefore for increasing blood safety, we decided to conduct this study and identify the outbreak of OBI and anti-HBc in HBsAg-negative donors in the Golestan province. 
Materials and Methods
Experimental design
The current cross-sectional study investigated All the subjects were asked to sign the written knowledgeable approval before the study.
Serological tests
All 3500 subjects were examined for HBs-Ag 
Statistical analysis
Data analysis was conducted with Chi-Square in SPSS software (v.13.5). In this examination, the results were noteworthy when P < 0.05.
Results
The and Germany, OBI pervasiveness rates of 0.006%, 0.22%, 0.05%, and 0.0006%, have been reported respectively. All in all, these data imply that the prevalence of OBI is distinctive in every country [11] .
OBI pervasiveness in multiple findings, on tests of anti-HBc positive as a distinctive indicator of HBV, has been reported to be 0% to >20%. Also, findings from India and Pakistan have indicated an average of 20.6%
OBI in anti-HBc-only blood donor the anti-HBc pervasiveness being around 20% [26] .
The results of the study conducted in Turkey has shown the absolute isolated rate of anti-HBc positivity in the analysis province being 2.5% (225/9107) and HBV-DNA positivity and in the HBsAg negative assembly was 0.011% (1/9100) [27] . 
Conclusion
Regarding the fact that anti-HBc has a high spread among blood donors in the Golestan province without the presence of HBV-DNA, anti-HBc screening can cause blood donor deferrals and limit blood supply. Therefore, reducing transmitted-HBV risk regarding the HBV transmissibility in preseroconversion window periods is higher than occult carriers.
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